RE:RE:RE:Beautiful cup and handleI have bought and sold MMED about a dozen times. I'm happy to buy it when it goes lower than $4, especially at the $3.50 range, but at $5 and higher it is too rich for my blood. I think they have some catching up to do to be worth close to that price. No question to me that TRIP offers much higher potential gains from current levels of each company. I can easily see TRIP doubling before end of spring, and tripling from current levels by end of summer. I think it will be quite a while before MMED doubles from current level.
trip2themoon wrote: I would say there is a much higher bull case for TRIP over MMED. MMED market cap and share structure is scary given they may never recognize revenue for years. CMPS is a much better play with FDA fasttrack and a low share count not to mention institutional investors. I've made some money on MMED but only hold it in the ETF.